Clinical trial Recruiting at 1 site Interventional Ages 25 to 75

Nutritional programs to improve metabolic health

Official title: Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Metabolic Conditions

Run by Viome · NCT05564273 · Data updated 2026-11-12

This study is testing if a special diet and supplements can help people with obesity improve their metabolic health over four months.

Quick facts

Study typeInterventional
Ages25 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorViome
Industry-sponsored
Locations1 site (Bothell, Washington)
StatusRecruiting
StartedOctober 13, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 29, 2025
Trial IDNCT05564273 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are U.S. residents aged 25-75 with obesity and elevated fasting insulin or glucose levels.

Probably not a fit

Patients who are unwilling to change their current diet or have recently made significant lifestyle changes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves U.S. residents with obesity who are randomized into three groups: a placebo group, a group receiving Viome's condition-based supplements, and a group following the Viome Precision Nutrition Program. Participants will complete a survey upon enrollment and will receive dietary recommendations and/or supplements aimed at improving metabolic wellness over a period of approximately four months. The study is designed to assess the effectiveness of these interventions in managing metabolic conditions without utilizing traditional clinical sites.

Why it matters

Potential benefit: If successful, this study could provide personalized nutritional strategies to improve metabolic health in individuals with obesity.

How similar studies have gone: While there have been studies on dietary interventions for metabolic health, this specific approach using Viome's personalized nutrition programs is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Resident of the United States
* Females and males ages 25-75 (inclusive)
* Able to speak and read English
* No unexplained weight loss, fevers, anemia, or blood in stool
* Willing and able to follow the trial instructions, as described in the recruitment letter
* Signed and dated informed consent prior to any trial-specific procedures.
* Fasting insulin level \>=15 uIU/mL or fasting glucose \>= 100 mg/dL within the last 3 months, verified from medical records

Exclusion Criteria:

* Unwilling to change current diet
* Unwilling to go to Quest
* Prior use of Viome products or services
* Antibiotic use in the previous 4 weeks
* Women who are pregnant (current or planned in the next 4 months), or breastfeeding
* \< 90 days postpartum
* Active infection
* Unable or unwilling to use Viome's App on an iPhone or Android smartphone
* Significant diet or lifestyle changes in the previous 1 month
* IBD diagnosis
* Use of investigational drugs, products or devices within 1 month prior to and 4 months after the start of the trial
* Cancer therapy within the previous 1 year
* Major surgery in the last 6 months or planned in the next 4 months
* Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.)
* Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.)
* Prescribed any drug(s) that may interact with the supplement formulations
* Have any medical condition or allergy that may interact with, or prevents the healthy consumption of the supplements such as:

Pregnancy Breastfeeding Minors GERD Gastric Ulcers Ulcerative Colitis Crohn's Disease Kidney Impairment (kidney cysts, kidney disease) Liver Condition (gallstones, cholecystitis, cirrhosis, hepatitis, hepatitis a, hepatitis b, hepatitis c, NAFLD/NASH, etc) HIV SIBO CuminAllergy GymnemaAllergy BacopaAllergy CitrusAIlergy LamiaceaeAllergy SageAllergy YeastAllergy MulberryAllergy ChicoryAllergy

* Allergies to any study-specific supplement ingredients
* Currently on a specific diet:

FODMAP KETO PALEO

* Gastrointestinal disease including:

  * GI surgery except:

    * Appendectomy and benign polypectomy
* Esophagitis
* Celiac disease
* GI malignancy or obstruction
* Peptic Ulcer Disease
* Duodenal or gastric ulcer disease

Where it's running

  • Viome Life Sciences
    Bothell, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.